EIT Health Catapult Finalists 2020

by admin

Oct 22

Zoan BioMed is delighted to announce it was successful in today’s semi final of the EIT Health Catapult Programme – earning its place in the final later this year. The line up of 40 semi finalists across MedTech, BioTech and Digital Health represent some of the most exciting innovations in healthcare across Europe today. Zoan BioMed’s achievement of its place in the final is further demonstration of its continued path towards commercialisation in 2021. We look forward to the next opportunity to showcase the opportunities that our platform offers.

We would like to thank EIT for its continued support and mentorship and look forward to our future collaborations together.

The finals take place in December and you can register to attend the finals as part of EIT’s Health Summit here.

EIT Health is supported by the European Institute of Innovation and Technology, a body of the European Union, to find out more visit https://eithealth.eu/

Latest News

Visiting Cellink

Thank you to the Cellink team for hosting us in their highly impressive facility in Gothenberg.

We are making excellent progress towards our development of 3D bioprinted tissue model containing sustainably grown coral skeletal particles.

5 days ago

Zoan and partners at TERMIS 2023

Zoan, Cellink and University of Galway collaboration on 3D printable coral-containing bioinks to present results at TERMIS, Manchester, 28-31st March 2023: Biocompatibility of 3D bioprinted tissue model prototypes containing sustainably grown coral skeletal particles for orthopedic applicationsE. Pernevik et. al. Zoan and partners at CELLINK and University of Galway will be presenting the early results from our coral bioink…

2 months ago

Our Sustainability Model

As a Med Tech company that aims to improve people’s health, we recognise the need to preserve a healthy environment. The link between human and environmental health is well established: the WHO states that one in four premature deaths is related to environmental issues caused by humans and the World Bank acknowledges that sustainable management…

3 months ago

Novel Collaboration between Zoan Biomed and University of Galway to Assess Laboratory Bone Formation

Zoan Biomed and the University of Galway to develop high throughput rapid assessment methods for biocompatibility and osteogenic potential of orthopaedic scaffold; reducing time to clinical data and developing a path to remove the need for animal testing.

5 months ago

Contact Us

To find out more about Zoan BioMed get in touch

  • *